[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335683-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335683-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","simultaneous-targeting-of-nqo1-and-sod1-eradicates-breast-cancer-stem-cells-via-mitochondrial-futile-redox-cycling","Simultaneous Targeting of NQO1 and SOD1 Eradicates Breast Cancer Stem Cells via Mitochondrial Futile Redox Cycling","","Triple-negative breast cancer (TNBC) contains abundant cancer stem-like cells (CSCs) that resist current therapies, with resistance partly driven by NRF2-regulated antioxidant pathways, including NQO1. This study identifies NQO1 and SOD1 as therapeutic vulnerabilities across ALDH+ epithelial-like and CD24-/loCD44+/hi mesenchymal-like CSC states in TNBC. Using the NQO1-bioactivatable futile redox cycling molecule IB-DNQ, researchers generated high reactive oxygen species, while enhancing CSC killing through SOD1 genetic or pharmacologic inhibition. Mechanistic data indicate mitochondrial NQO1-mediated futile redox cycling, potentiated oxidative injury, cytochrome c release, and caspase-3 apoptosis activation. In xenograft models, IB-DNQ with or without SOD1 inhibition suppressed tumor growth, metastasis, and tumor-initiating potential, supporting a CSC-targeting therapeutic strategy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/simultaneous-targeting-of-nqo1-and-sod1-eradicates-breast-cancer-stem-cells-via-mitochondrial-futile-redox-cycling/335683/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/simultaneous-targeting-of-nqo1-and-sod1-eradicates-breast-cancer-stem-cells-via-mitochondrial-futile-redox-cycling/335683.png","ImageObject",300,407,{"name":42,"@type":43},"Clementine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are cancer stem-like cells important in triple-negative breast cancer?","Question",{"text":63,"@type":64},"TNBC contains a high proportion of cancer stem-like cells that contribute to treatment resistance and tumor recurrence, making them critical targets for improving outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role do NQO1 and SOD1 play in the study’s strategy?",{"text":68,"@type":64},"The study identifies NQO1 and SOD1 as therapeutic vulnerabilities of TNBC cancer stem-like cells, linking antioxidant defense pathways to susceptibility under specific targeting conditions.",{"name":70,"@type":61,"acceptedAnswer":71},"How does IB-DNQ eradicate breast cancer stem cells?",{"text":72,"@type":64},"IB-DNQ is an NQO1-bioactivatable futile redox cycling molecule that generates reactive oxygen species. The effect is further enhanced by inhibiting SOD1, leading to mitochondrial oxidative injury, cytochrome c release, and caspase-3–mediated apoptosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335683,1790126531,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":4},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Simultaneous Targeting of NQO1 and SOD1 Eradicates Breast Cancer Stem Cells via Mitochondrial Futile Redox Cycling  \nMing Luo1,2, Na Shen2,3, Li Shang2, Zeng Fang1,2, Ying Xin2, Yuxi Ma2,4, Min Du1, Yuan Yuan1, Chenchen Hu1, Yun Tang1, Jing Huang1, Wei Wei1, Myung Ryul Lee5, Paul J. Hergenrother5, and Max S. Wicha2  \n|  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n|  | Triple-negative breast cancer (TNBC) contains the highest proportion of cancer stem-like cells (CSC), which display intrinsic resistance to currently available cancer therapies. This therapeutic resistance is partially mediated by an antioxidant defense coordinated by the transcription factor NRF2 and its downstream targets that include NAD(P)H quinone oxidoreductase 1 (NQO1). In this study, we identified the antioxidant enzymes NQO1 and superoxide dismutase 1 (SOD1) as therapeutic vulnerabilities of ALDH+ epithelial-like CSCs and CD24􀀁/loCD44+/hi mesenchymallike CSCs in TNBC. Effective targeting of these CSC states was achieved by using isobutyl-deoxynyboquinone (IB-DNQ), a potent and specific NQO1-bioactivatable futile redox cycling molecule, which generated large amounts of reactive oxygen species including superoxide and hydrogen peroxide. Furthermore, the CSC killing effect was specifically enhanced by genetic or pharmacologic inhibition of SOD1, a copper-containing superoxide dismutase highly expressed in TNBC. Mechanistically, a significant portion of\u003Cbr>􀀶 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | NQO1 resides in the mitochondrial intermembrane space, catalyzing futile redox cycling from IB-DNQ to generate high levels of mitochondrial superoxide, and SOD1 inhibition markedly potentiated this effect, resulting in mitochondrial oxidative injury, cytochrome c release, and activation of the caspase-3–mediated apoptotic pathway. Treatment with IB-DNQ alone or together with SOD1 inhibition effectively suppressed tumor growth, metastasis, and tumor-initiating potential in xenograft models of TNBC expressing different levels of NQO1. This futile oxidant-generating strategy, which targets CSCs across the epithelial–mesenchymal continuum, could be a promising therapeutic approach for treating patients with TNBC.\u003Cbr>Significance: Combining NQO1-bioactivatable futile oxidant generators with SOD1 inhibition eliminates breast cancer stem cells, providing a therapeutic strategy that may have wide applicability, as NQO1 and SOD1 are overexpressed in several cancers. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nTriple-negative breast cancer (TNBC) is a very aggressive breast cancer subtype with the least favorable prognosis and few treatment options (1, 2) . It is also characterized as containing a high proportion of cancer stem-like cells (CSC; refs. 3–5) that contribute to treatment resistance and tumor recurrence (6–9) . Many conventional therapies used to treat TNBC such as chemotherapy and radiation ","cbCairvLZ2q0MnCj","https://ap.wps.com/l/cbCairvLZ2q0MnCj","pdf",36937280,"English","# Introduction\n## Background on TNBC and cancer stem-like cells\n## Rationale for targeting NQO1 and SOD1\n## Overview of the study approach","[{\"question\":\"Why are cancer stem-like cells important in triple-negative breast cancer?\",\"answer\":\"TNBC contains a high proportion of cancer stem-like cells that contribute to treatment resistance and tumor recurrence, making them critical targets for improving outcomes.\"},{\"question\":\"What role do NQO1 and SOD1 play in the study’s strategy?\",\"answer\":\"The study identifies NQO1 and SOD1 as therapeutic vulnerabilities of TNBC cancer stem-like cells, linking antioxidant defense pathways to susceptibility under specific targeting conditions.\"},{\"question\":\"How does IB-DNQ eradicate breast cancer stem cells?\",\"answer\":\"IB-DNQ is an NQO1-bioactivatable futile redox cycling molecule that generates reactive oxygen species. The effect is further enhanced by inhibiting SOD1, leading to mitochondrial oxidative injury, cytochrome c release, and caspase-3–mediated apoptosis.\"}]","Simultaneous Targeting of NQO1 and SOD1 Eradicates Breast Cancer Stem Cells via Mitochondrial Futile Redox Cycling | PDF",1790011932,48]